-
Symbol
-
MRSN
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
0 shares
-
Security Ownership %
-
0%
Bain Capital Life Sciences Fund II, L.P. ownership in Mersana Therapeutics, Inc. Common Stock, par value $0.0001 per share (MRSN)
08 Jan 2026 - Bain Capital Life Sciences Fund II, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Mersana Therapeutics, Inc. Common Stock, par value $0.0001 per share (MRSN).
This represents 0% ownership of the company.
In their previous filing dated 13 Nov 2025, Bain Capital Life Sciences Fund II, L.P. had reported owning 198,720 shares, indicating a decrease of +100%.
.